Giloralimab
Product Specifications
UNSPSC Description
Giloralimab (ABBV-927) is a potent antiCD40 agonistic monoclonal antibody. Giloralimab has the potential for the research of cancer[1][2].
Target Antigen
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/giloralimab.html
Purity
96.10
Solubility
10 mM in DMSO
Smiles
[Giloralimab]
References & Citations
[1]Boulard P, et al. Finding the Right Heavy Chains for Immunostimulatory Antibodies. Int J Mol Sci. 2022 Sep 8;23(18):10367.|[2]Peng L, et al. Novel immunotherapeutic drugs for the treatment of lung cancer. Curr Opin Oncol. 2022 Jan 1;34(1):89-94.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99640/Giloralimab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99640/Giloralimab-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
2226292-20-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![N-[4-(2-Amino-thiazol-4-yl)-phenyl]-4-chloro-benzenesulfonamide](https://cdn.genprice.uk/genprice/genprice3.png)
